AI Article Synopsis
- Thrombosis is a common sign of both antiphospholipid syndrome (APS) and COVID-19, and their related mechanisms are still under investigation.
- The presence of antiphospholipid antibodies (aPLs) in severe COVID-19 cases is significant but does not necessarily relate to worse outcomes or thrombosis risk.
- Vaccination with mRNA vaccines shows good tolerance in APS patients with aPL, suggesting that vaccination may reduce hesitancy among those at risk.
Article Abstract
Thrombosis is one of the many signs of antiphospholipid syndrome (APS) and COVID-19 infection. Although the mechanisms contributing to thrombosis in APS and COVID-19 are relatively similar, this remains an open subject. Even now (when the COVID-19 pandemic has subsided), there is no conclusive solution to APS and COVID-19 co-occurrence. The presence of newly generated antiphospholipid antibodies (aPLs) in COVID-19 infection may or may not be connected to the diagnosis of APS. The prevalence of aPLs is substantial in severe COVID-19 but not related to thrombosis or a worse outcome. Adequate monitoring of antibody positivity over time is recommended for APL diagnosis. On the other hand, thrombosis and thrombocytopenia can rarely occur with vaccination with mRNA vaccines. Some studies have shown that COVID-19 immunization is well tolerated among APS patients who are triple-positive for aPL, which may comfort patients and referring physicians and lessen hesitation in unvaccinated APS/aPL-positive patients. In this narrative review, we will give an overview of the interaction between aPL-APS-COVID-19-thrombosis and related diagnostic insights learned during the pandemic.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00296-023-05531-y | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Effect of Contralateral Routing of Signal Devices on the Quality of Life of Unilateral Cochlear Implant Recipients and Their Frequent Communication Partners.
Am J Audiol
January 2025
Department of Otolaryngology, University of Utah, Salt Lake City.
Purpose: Unilateral cochlear implant (CI) recipients with limited hearing in the contralateral ear are deprived of the advantages of binaural hearing. To address speech recognition challenges arising from the head shadow effect, a contralateral routing of signal (CROS) device can be used; however, less is known of the broader impact of a CROS device on an individual's quality of life (QoL) or that of their frequent communication partners (FCPs). This preliminary study aimed to evaluate the impact of CROS on speech recognition in noise and its influence on the QoL of unilateral CI recipients and their FCPs.
View Article and Find Full Text PDFThe Impact of Vaccination on COVID-19 Outcomes in Vietnam.
Diagnostics (Basel)
December 2024
Hanoi Medical University Hospital, Hanoi 100000, Vietnam.
: This study aimed to assess the effectiveness of the COVID-19 vaccine on the outcomes of patients in three hospitals in Vietnam. : An observational study involved 3102 confirmed COVID-19 patients from Vietnam. Participants were classified into unvaccinated, partially vaccinated (one dose) (PV), fully vaccinated (two doses) (FV), and boosted (three doses) groups.
View Article and Find Full Text PDFImmune changes in pregnancy: associations with pre-existing conditions and obstetrical complications at the 20th gestational week-a prospective cohort study.
BMC Med
December 2024
Department of Obstetrics and Gynecology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
Background: Pregnancy is a complex biological process and serious complications can arise when the delicate balance between the maternal and semi-allogeneic fetal immune systems is disrupted or challenged. Gestational diabetes mellitus (GDM), pre-eclampsia, preterm birth, and low birth weight pose serious threats to maternal and fetal health. Identification of early biomarkers through an in-depth understanding of molecular mechanisms is critical for early intervention.
View Article and Find Full Text PDFPrediction of antigenic peptides of SARS- CoV-2 pathogen using machine learning.
PeerJ Comput Sci
October 2024
Department of Electrical & Electronics Engineering Faculty of Engineering and the Built Environment, University of Johannesburg, Johannesburg, South Africa.
Antigenic peptides (APs), also known as T-cell epitopes (TCEs), represent the immunogenic segment of pathogens capable of inducing an immune response, making them potential candidates for epitope-based vaccine (EBV) design. Traditional wet lab methods for identifying TCEs are expensive, challenging, and time-consuming. Alternatively, computational approaches employing machine learning (ML) techniques offer a faster and more cost-effective solution.
View Article and Find Full Text PDFPrevalence of antiphospholipid antibodies in COVID-19 patients: A meta-analysis.
Vascul Pharmacol
December 2024
Department of Geriatric, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou 310006, Zhejiang Province, China; Zhejiang Provincial Key laboratory of Traditional Chinese Medicine for the Prevention and Treatment of Major Chronic Disease in the Elderly, Hangzhou 310006, Zhejiang Province, China. Electronic address:
Objective: In some reports, antiphospholipid antibodies (aPL) prevalence is higher in COVID-19 patients. This study intended to compare aPL prevalence between COVID-19 patients and healthy controls, and differences in aPL types using meta-analysis.
Methods: This work retrieved published literature about association between COVID-19 and aPL from Embase, Web of Science, PubMed, and The Cochrane Library databases.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!